Anti–CTLA-4 therapy broadens the melanoma-reactive CD8 + T cell response

Kvistborg et al. (Wed,) studied this question.

www.synapsesocial.com/papers/69865a14c55aa016525d0f12 — DOI: https://doi.org/10.1126/scitranslmed.3008918

Also consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. Tumor Exome Analysis Reveals Neoantigen-Specific T-Cell Reactivity in an Ipilimumab-Responsive Melanoma· 2013 · 798 citations
2. Cytolytic T‐cell responses of cancer patients vaccinated with a MAGE antigen· 2002 · 123 citations
3. The Interaction Properties of Costimulatory Molecules Revisited· 2002 · 676 citations
4. Enhancement of Antitumor Immunity by CTLA-4 Blockade· 1996 · 3,899 citations
5. Tumor antigen–specific CD8 T cells infiltrating the tumor express high levels of PD-1 and are functionally impaired· 2009 · 1,757 citations